Can a bladder drug re-energize aging bodies?
NCT ID NCT06987383
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This 12-week study tests whether Vibegron, a drug already approved for overactive bladder, can improve energy use, heart health, and physical and mental function in 40 middle-aged and older adults with obesity. Participants will be randomly assigned to receive either Vibegron or a placebo. The goal is to see if this drug can help counter age- and obesity-related decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.